Bill

Bill > SB195


GA SB195

GA SB195
Pharmacies; pharmacists are authorized to dispense preexposure prophylaxis and postexposure prophylaxis under certain conditions; provide


summary

Introduced
02/18/2025
In Committee
01/29/2026
Crossed Over
03/03/2025
Passed
Dead

Introduced Session

2025-2026 Regular Session

Bill Summary

AN ACT To amend Article 6 of Chapter 4 of Title 26 of the Official Code of Georgia Annotated, relating to pharmacies, so as to provide that pharmacists are authorized to dispense preexposure prophylaxis and postexposure prophylaxis under certain conditions; to amend Article 2 of Chapter 34 of Title 43 of the Official Code of Georgia Annotated, relating to medical practice, so as to provide for the approval or development of a training program for pharmacists by the State Board of Pharmacy; to require pharmacists to complete such training program before dispensing preexposure prophylaxis or postexposure prophylaxis; to provide for patient requirements; to provide for limitations and conditions; to provide for sanctions; to provide for definitions; to provide for related matters; to repeal conflicting laws; and for other purposes.

AI Summary

This bill authorizes pharmacists in Georgia to dispense and administer preexposure prophylaxis (PrEP) and postexposure prophylaxis (PEP), which are medications used to prevent HIV infection, under specific conditions. To do so, pharmacists must complete an approved training program covering the pharmacology of these drugs, contraindications, financial assistance programs, and relevant federal guidelines, with this training to be approved by January 1, 2027. Pharmacists can dispense a 30 to 90-day supply of PrEP or administer a long-acting injectable form if the patient is HIV-negative (verified by a recent test or a test administered by the pharmacist), does not take contraindicated medications, and the pharmacist documents the services provided and notifies the patient's primary care provider or offers a list of healthcare providers for ongoing care. For PEP, pharmacists can dispense a 30-day supply if the patient meets the Centers for Disease Control and Prevention (CDC) clinical criteria and the patient's primary care provider is notified or the patient is provided with follow-up care resources. The bill also establishes protocols for physicians to delegate the authority to prescribe long-acting injectable PrEP and PEP to pharmacists through written agreements, outlining requirements for consultation, patient history, documentation, adverse event procedures, and insurance coverage, with limitations on the number of pharmacists a physician can contract with and specific sanctions for non-compliance.

Committee Categories

Health and Social Services

Sponsors (6)

Last Action

House Passed/Adopted By Substitute (on 02/12/2026)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...